Spyre Therapeutics, Inc. (SYRE)
106.65
+0.16
(+0.15%)
USD |
NASDAQ |
Aug 24, 16:00
107.01
+0.36
(+0.34%)
Pre-Market: 08:18
Spyre Therapeutics Total Assets (Quarterly) : 1.173B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.173B |
| March 31, 2026 | 763.95M |
| December 31, 2025 | 777.78M |
| September 30, 2025 | 504.60M |
| June 30, 2025 | 538.83M |
| March 31, 2025 | 569.78M |
| December 31, 2024 | 608.48M |
| September 30, 2024 | 421.09M |
| June 30, 2024 | 436.07M |
| March 31, 2024 | 487.60M |
| December 31, 2023 | 341.86M |
| September 30, 2023 | 207.26M |
| June 30, 2023 | 243.53M |
| March 31, 2023 | 52.45M |
| December 31, 2022 | 71.14M |
| September 30, 2022 | 91.57M |
| June 30, 2022 | 106.71M |
| March 31, 2022 | 83.17M |
| December 31, 2021 | 109.93M |
| September 30, 2021 | 129.06M |
| June 30, 2021 | 146.98M |
| March 31, 2021 | 163.61M |
| December 31, 2020 | 161.62M |
| September 30, 2020 | 155.63M |
| Date | Value |
|---|---|
| June 30, 2020 | 172.91M |
| March 31, 2020 | 64.78M |
| December 31, 2019 | 83.18M |
| September 30, 2019 | 100.10M |
| June 30, 2019 | 117.49M |
| March 31, 2019 | 128.52M |
| December 31, 2018 | 77.74M |
| September 30, 2018 | 71.28M |
| June 30, 2018 | 79.71M |
| March 31, 2018 | 49.79M |
| December 31, 2017 | 56.08M |
| September 30, 2017 | 60.50M |
| June 30, 2017 | 67.14M |
| March 31, 2017 | 61.27M |
| December 31, 2016 | 67.06M |
| September 30, 2016 | 72.06M |
| June 30, 2016 | 77.30M |
| March 31, 2016 | 35.54M |
| December 31, 2015 | 38.65M |
| September 30, 2015 | 42.10M |
| June 30, 2015 | 45.64M |
| March 31, 2015 | 44.35M |
| December 31, 2014 | 2.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 135.12B |
| vTv Therapeutics, Inc. | 87.59M |
| BridgeBio Pharma, Inc. | 1.217B |
| Praxis Precision Medicines, Inc. | 1.390B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 71.86M |
| Shareholders Equity (Quarterly) | 1.101B |
| Current Ratio | 18.53 |